{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:42:17Z","timestamp":1792658537307,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Many recent studies have shown that the gut microbiome plays important roles in human physiology and pathology. Also, microbiome-based therapies have been used to improve health status and treat diseases. In addition, aging and neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, have become topics of intense interest in biomedical research. Several researchers have explored the links between these topics to study the potential pathogenic or therapeutic effects of intestinal microbiota in disease. But the exact relationship between neurodegenerative diseases and gut microbiota remains unclear. As technology advances, new techniques for studying the microbiome will be developed and refined, and the relationship between diseases and gut microbiota will be revealed. This article summarizes the known interactions between the gut microbiome and neurodegenerative diseases, highlighting assay techniques for the gut microbiome, and we also discuss the potential therapeutic role of microbiome-based therapies in diseases.<\/jats:p>","DOI":"10.1007\/s12264-021-00730-8","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T08:02:35Z","timestamp":1625299355000},"page":"1510-1522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["The Relationship Between the Gut Microbiome and Neurodegenerative Diseases"],"prefix":"10.1007","volume":"37","author":[{"given":"Xueling","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoxiang","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-0593","authenticated-orcid":false,"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1572-0241.2006.00456.x","volume":"101","author":"MC Dubinsky","year":"2006","unstructured":"Dubinsky MC, Lin YC, Dutridge D, Picornell Y, Landers CJ, Farrior S. Serum immune responses predict rapid disease progression among children with Crohn\u2019s disease: Immune responses predict disease progression. Am J Gastroenterol 2006, 101: 360\u2013367.","journal-title":"Am J Gastroenterol"},{"key":"730_CR2","doi-asserted-by":"crossref","unstructured":"Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007, 104: 13780\u201313785.","DOI":"10.1073\/pnas.0706625104"},{"key":"730_CR3","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3945\/jn.109.104380","volume":"139","author":"SJ O'Keefe","year":"2009","unstructured":"O\u2019Keefe SJ, Ou JH, Aufreiter S, O\u2019Connor D, Sharma S, Sepulveda J, et al. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr 2009, 139: 2044\u20132048.","journal-title":"J Nutr"},{"key":"730_CR4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s11427-016-5083-9","volume":"59","author":"X Hu","year":"2016","unstructured":"Hu X, Wang T, Jin F. Alzheimer\u2019s disease and gut microbiota. Sci China Life Sci 2016, 59: 1006\u20131023.","journal-title":"Sci China Life Sci"},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 2016, 167: 1469-1480.e12.","journal-title":"Cell"},{"key":"730_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jama.2016.20099","volume":"317","author":"AL Komaroff","year":"2017","unstructured":"Komaroff AL. The microbiome and risk for obesity and diabetes. JAMA 2017, 317: 355\u2013356.","journal-title":"JAMA"},{"key":"730_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/0884533615609896","volume":"30","author":"GM Barlow","year":"2015","unstructured":"Barlow GM, Yu A, Mathur R. Role of the gut microbiome in obesity and diabetes mellitus. Nutr Clin Pract 2015, 30: 787\u2013797.","journal-title":"Nutr Clin Pract"},{"key":"730_CR8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01202","author":"JU Scher","year":"2013","unstructured":"Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013, https:\/\/doi.org\/10.7554\/eLife.01202.","journal-title":"Elife"},{"key":"730_CR9","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/jcp.24636","volume":"229","author":"RA Britton","year":"2014","unstructured":"Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, et al. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol 2014, 229: 1822\u20131830.","journal-title":"J Cell Physiol"},{"key":"730_CR10","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/art.39107","volume":"67","author":"AT Vieira","year":"2015","unstructured":"Vieira AT, Macia L, Galv\u00e3o I, Martins FS, Canesso MC, Amaral FA, et al. A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol 2015, 67: 1646\u20131656.","journal-title":"Arthritis Rheumatol"},{"key":"730_CR11","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med 2016, 375: 2369\u20132379.","journal-title":"N Engl J Med"},{"key":"730_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.arr.2016.06.005","volume":"29","author":"JP da Costa","year":"2016","unstructured":"da Costa JP, Vitorino R, Silva GM, Vogel C, Duarte AC, Rocha-Santos T. A synopsis on aging-Theories, mechanisms and future prospects. Ageing Res Rev 2016, 29: 90\u2013112.","journal-title":"Ageing Res Rev"},{"key":"730_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/WCO.0000000000000496","volume":"30","author":"M Marizzoni","year":"2017","unstructured":"Marizzoni M, Provasi S, Cattaneo A, Frisoni GB. Microbiota and neurodegenerative diseases. Curr Opin Neurol 2017, 30: 630\u2013638.","journal-title":"Curr Opin Neurol"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gtc.2016.09.007","volume":"46","author":"TG Dinan","year":"2017","unstructured":"Dinan TG, Cryan JF. The microbiome-gut-brain axis in health and disease. Gastroenterol Clin North Am 2017, 46: 77\u201389.","journal-title":"Gastroenterol Clin North Am"},{"key":"730_CR15","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1126\/science.aac8469","volume":"350","author":"PW O'Toole","year":"2015","unstructured":"O\u2019Toole PW, Jeffery IB. Gut microbiota and aging. Science 2015, 350: 1214\u20131215.","journal-title":"Science"},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5056\/jnm18087","volume":"25","author":"K Kowalski","year":"2019","unstructured":"Kowalski K, Mulak A. Brain-gut-microbiota axis in Alzheimer\u2019s disease. J Neurogastroenterol Motil 2019, 25: 48\u201360.","journal-title":"J Neurogastroenterol Motil"},{"key":"730_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmech.2017.07.070","volume":"139","author":"M Jouanne","year":"2017","unstructured":"Jouanne M, Rault S, Voisin-Chiret AS. Tau protein aggregation in Alzheimer\u2019s disease: An attractive target for the development of novel therapeutic agents. Eur J Med Chem 2017, 139: 153\u2013167.","journal-title":"Eur J Med Chem"},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.2174\/1381612822666160907093807","volume":"22","author":"CA K\u00f6hler","year":"2016","unstructured":"K\u00f6hler CA, Maes M, Slyepchenko A, Berk M, Solmi M, Lanct\u00f4t KL, et al. The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: Mechanisms and pathophysiological role in Alzheimer\u2019s disease. Curr Pharm Des 2016, 22: 6152\u20136166.","journal-title":"Curr Pharm Des"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 2017, 49: 60\u201368.","journal-title":"Neurobiol Aging"},{"key":"730_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.phrs.2017.12.009","volume":"129","author":"C Mancuso","year":"2018","unstructured":"Mancuso C, Santangelo R. Alzheimer\u2019s disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence. Pharmacol Res 2018, 129: 329\u2013336.","journal-title":"Pharmacol Res"},{"key":"730_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161141","volume":"58","author":"C Jiang","year":"2017","unstructured":"Jiang C, Li G, Huang P, Liu Z, Zhao B. The gut microbiota and Alzheimer\u2019s disease. J Alzheimers Dis 2017, 58: 1\u201315.","journal-title":"J Alzheimers Dis"},{"key":"730_CR22","doi-asserted-by":"crossref","unstructured":"Haran JP, Bhattarai SK, Foley SE, Dutta P, Ward DV, Bucci V, et al. Alzheimer's disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway. mBio 2019, 10: e00632\u2013e00619.","DOI":"10.1128\/mBio.00632-19"},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 2020, 69: 283\u2013294.","journal-title":"Gut"},{"key":"730_CR24","doi-asserted-by":"publisher","first-page":"E1689","DOI":"10.3390\/ijms19061689","volume":"19","author":"V Caputi","year":"2018","unstructured":"Caputi V, Giron MC. Microbiome-gut-brain axis and toll-like receptors in Parkinson\u2019s disease. Int J Mol Sci 2018, 19: E1689.","journal-title":"Int J Mol Sci"},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2017.05.042","volume":"817","author":"P Perez-Pardo","year":"2017","unstructured":"Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, et al. The gut-brain axis in Parkinson\u2019s disease: Possibilities for food-based therapies. Eur J Pharmacol 2017, 817: 86\u201395.","journal-title":"Eur J Pharmacol"},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","volume":"27","author":"VD Felice","year":"2016","unstructured":"Felice VD, Quigley EM, Sullivan AM, O\u2019Keeffe GW, O\u2019Mahony SM. Microbiota-gut-brain signalling in Parkinson\u2019s disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 2016, 27: 1\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"730_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2019.00239","volume":"10","author":"J Campos-Acu\u00f1a","year":"2019","unstructured":"Campos-Acu\u00f1a J, Elgueta D, Pacheco R. T-cell-driven inflammation as a mediator of the gut-brain axis involved in Parkinson\u2019s disease. Front Immunol 2019, 10: 239.","journal-title":"Front Immunol"},{"key":"730_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 2015, 30: 350\u2013358.","journal-title":"Mov Disord"},{"key":"730_CR29","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson\u2019s disease. World J Gastroenterol 2015, 21: 10609\u201310620.","journal-title":"World J Gastroenterol"},{"key":"730_CR30","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, et al. Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 2015, 30: 1351\u20131360.","journal-title":"Mov Disord"},{"key":"730_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40168-020-00988-6","volume":"9","author":"YF Hou","year":"2021","unstructured":"Hou YF, Shan C, Zhuang SY, Zhuang QQ, Ghosh A, Zhu KC, et al. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease. Microbiome 2021, 9: 34.","journal-title":"Microbiome"},{"key":"730_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jneuroim.2019.01.004","volume":"328","author":"S Roy Sarkar","year":"2019","unstructured":"Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. J Neuroimmunol 2019, 328: 98\u2013104.","journal-title":"J Neuroimmunol"},{"key":"730_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuint.2018.08.005","volume":"120","author":"LJ Spielman","year":"2018","unstructured":"Spielman LJ, Gibson DL, Klegeris A. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. Neurochem Int 2018, 120: 149\u2013163.","journal-title":"Neurochem Int"},{"key":"730_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-018-1856-5","volume":"136","author":"C Pellegrini","year":"2018","unstructured":"Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: A common path to neurodegenerative diseases? Acta Neuropathol 2018, 136: 345\u2013361.","journal-title":"Acta Neuropathol"},{"key":"730_CR35","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3109\/00207454.2015.1096271","volume":"126","author":"X Fang","year":"2016","unstructured":"Fang X. Potential role of gut microbiota and tissue barriers in Parkinson\u2019s disease and amyotrophic lateral sclerosis. Int J Neurosci 2016, 126: 771\u2013776.","journal-title":"Int J Neurosci"},{"key":"730_CR36","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 2019, 572: 474\u2013480.","journal-title":"Nature"},{"key":"730_CR37","unstructured":"Bianchi VE, Herrera PF, Laura R. Effect of nutrition on neurodegenerative diseases. A systematic review. Nutr Neurosci 2019: 1\u201325."},{"key":"730_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.phrs.2015.08.002","volume":"100","author":"S Sharma","year":"2015","unstructured":"Sharma S, Taliyan R. Transcriptional dysregulation in Huntington\u2019s disease: The role of histone deacetylases. Pharmacol Res 2015, 100: 157\u2013169.","journal-title":"Pharmacol Res"},{"key":"730_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.24901","volume":"81","author":"H Tremlett","year":"2017","unstructured":"Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. The gut microbiome in human neurological disease: A review. Ann Neurol 2017, 81: 369\u2013382.","journal-title":"Ann Neurol"},{"key":"730_CR40","doi-asserted-by":"publisher","first-page":"105199","DOI":"10.1016\/j.nbd.2020.105199","volume":"148","author":"G Kong","year":"2021","unstructured":"Kong G, Ellul S, Narayana VK, Kanojia K, Ha HTT, Li SS, et al. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington\u2019s disease. Neurobiol Dis 2021, 148: 105199.","journal-title":"Neurobiol Dis"},{"key":"730_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi C, Bonaf\u00e8 M, Valensin S, Olivieri F, de Luca M, Ottaviani E, et al. Inflamm-aging An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000, 908: 244\u2013254.","journal-title":"Ann N Y Acad Sci"},{"key":"730_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-cellbio-011620-034148","volume":"36","author":"D Frasca","year":"2020","unstructured":"Frasca D, Diaz A, Romero M, Garcia D, Blomberg BB. B Cell Immunosenescence. Annu Rev Cell Dev Biol 2020, 36: 551\u2013574.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"730_CR43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molmed.2014.05.002","volume":"20","author":"YE Borre","year":"2014","unstructured":"Borre YE, O\u2019Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: Implications for brain disorders. Trends Mol Med 2014, 20: 509\u2013518.","journal-title":"Trends Mol Med"},{"key":"730_CR44","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1007\/s00018-017-2550-9","volume":"74","author":"S Westfall","year":"2017","unstructured":"Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: Deciphering the gut brain axis. Cell Mol Life Sci 2017, 74: 3769\u20133787.","journal-title":"Cell Mol Life Sci"},{"key":"730_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.arcmed.2017.11.005","volume":"48","author":"C Garc\u00eda-Pe\u00f1a","year":"2017","unstructured":"Garc\u00eda-Pe\u00f1a C, \u00c1lvarez-Cisneros T, Quiroz-Baez R, Friedland RP. Microbiota and Aging. Arch Med Res 2017, 48: 681\u2013689.","journal-title":"Arch Med Res"},{"key":"730_CR46","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.cub.2016.04.016","volume":"26","author":"E Biagi","year":"2016","unstructured":"Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, et al. Gut microbiota and extreme longevity. Curr Biol 2016, 26: 1480\u20131485.","journal-title":"Curr Biol"},{"key":"730_CR47","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev 2019, 99: 1877\u20132013.","journal-title":"Physiol Rev"},{"key":"730_CR48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12866-017-1101-8","volume":"17","author":"I Allali","year":"2017","unstructured":"Allali I, Arnold JW, Roach J, Cadenas MB, Butz N, Hassan HM, et al. A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome. BMC Microbiol 2017, 17: 194.","journal-title":"BMC Microbiol"},{"key":"730_CR49","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/ismej.2017.119","volume":"11","author":"BJ Callahan","year":"2017","unstructured":"Callahan BJ, McMurdie PJ, Holmes SP. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis. ISME J 2017, 11: 2639\u20132643.","journal-title":"ISME J"},{"key":"730_CR50","doi-asserted-by":"crossref","unstructured":"Amir A, McDonald D, Navas-Molina JA, Kopylova E, Morton JT, Zech Xu Z, et al. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems 2017, 2: e00191\u2013e00116.","DOI":"10.1128\/mSystems.00191-16"},{"key":"730_CR51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods 2016, 13: 581\u2013583.","journal-title":"Nat Methods"},{"key":"730_CR52","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbrc.2015.12.083","volume":"469","author":"R Ranjan","year":"2016","unstructured":"Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: Advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun 2016, 469: 967\u2013977.","journal-title":"Biochem Biophys Res Commun"},{"key":"730_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40168-018-0535-z","volume":"6","author":"C Mukherjee","year":"2018","unstructured":"Mukherjee C, Beall CJ, Griffen AL, Leys EJ. High-resolution ISR amplicon sequencing reveals personalized oral microbiome. Microbiome 2018, 6: 153.","journal-title":"Microbiome"},{"key":"730_CR54","doi-asserted-by":"publisher","first-page":"e0146423","DOI":"10.1371\/journal.pone.0146423","volume":"11","author":"M Davids","year":"2016","unstructured":"Davids M, Hugenholtz F, Martins-dos-Santos V, Smidt H, Kleerebezem M, Schaap PJ. Functional profiling of unfamiliar microbial communities using a validated de novo assembly metatranscriptome pipeline. PLoS One 2016, 11: e0146423. https:\/\/doi.org\/10.1371\/journal.pone.0146423.","journal-title":"PLoS One"},{"key":"730_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mimet.2010.10.018","volume":"84","author":"JY Wu","year":"2011","unstructured":"Wu JY, Gao WM, Zhang WW, Meldrum DR. Optimization of whole-transcriptome amplification from low cell density deep-sea microbial samples for metatranscriptomic analysis. J Microbiol Methods 2011, 84: 88\u201393.","journal-title":"J Microbiol Methods"},{"key":"730_CR56","doi-asserted-by":"crossref","unstructured":"Deng ZL, Gottschick C, Bhuju S, Masur C, Abels C, Wagner-D\u00f6bler I. Metatranscriptome analysis of the vaginal microbiota reveals potential mechanisms for protection against metronidazole in bacterial vaginosis. mSphere 2018, 3: e00262\u2013e00218.","DOI":"10.1128\/mSphereDirect.00262-18"},{"key":"730_CR57","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/1471-0528.15978","volume":"127","author":"HL Berman","year":"2020","unstructured":"Berman HL, McLaren MR, Callahan BJ. Understanding and interpreting community sequencing measurements of the vaginal microbiome. BJOG 2020, 127: 139\u2013146.","journal-title":"BJOG"},{"key":"730_CR58","doi-asserted-by":"publisher","first-page":"e0227886","DOI":"10.1371\/journal.pone.0227886","volume":"15","author":"YW Chung","year":"2020","unstructured":"Chung YW, Gwak HJ, Moon S, Rho M, Ryu JH. Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses. PLoS One 2020, 15: e0227886. https:\/\/doi.org\/10.1371\/journal.pone.0227886.","journal-title":"PLoS One"},{"key":"730_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/omi.2017.0077","volume":"22","author":"S Malan-Muller","year":"2018","unstructured":"Malan-Muller S, Valles-Colomer M, Raes J, Lowry CA, Seedat S, Hemmings SMJ. The gut microbiome and mental health: Implications for anxiety- and trauma-related disorders. OMICS 2018, 22: 90\u2013107.","journal-title":"OMICS"},{"key":"730_CR60","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1021\/acs.jproteome.9b00054","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang X, Figeys D. Perspective and guidelines for metaproteomics in microbiome studies. J Proteome Res 2019, 18: 2370\u20132380.","journal-title":"J Proteome Res"},{"key":"730_CR61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12866-016-0917-y","volume":"17","author":"TJ Snelling","year":"2017","unstructured":"Snelling TJ, Wallace RJ. The rumen microbial metaproteome as revealed by SDS-PAGE. BMC Microbiol 2017, 17: 9.","journal-title":"BMC Microbiol"},{"key":"730_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ismej.2013.120","volume":"8","author":"F L\u00fc","year":"2014","unstructured":"L\u00fc F, Bize A, Guillot A, Monnet V, Madigou C, Chapleur O, et al. Metaproteomics of cellulose methanisation under thermophilic conditions reveals a surprisingly high proteolytic activity. ISME J 2014, 8: 88\u2013102.","journal-title":"ISME J"},{"key":"730_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/WNR.0000000000000985","volume":"29","author":"Z Chen","year":"2018","unstructured":"Chen Z, Li J, Gui SW, Zhou CJ, Chen JJ, Yang CC, et al. Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder. Neuroreport 2018, 29: 417\u2013425.","journal-title":"Neuroreport"},{"key":"730_CR64","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jprot.2017.07.001","volume":"180","author":"X Zhang","year":"2018","unstructured":"Zhang X, Li LY, Mayne J, Ning ZB, Stintzi A, Figeys D. Assessing the impact of protein extraction methods for human gut metaproteomics. J Proteomics 2018, 180: 120\u2013127.","journal-title":"J Proteomics"},{"key":"730_CR65","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/mas.21553","volume":"38","author":"HM Luan","year":"2019","unstructured":"Luan HM, Wang X, Cai ZW. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders. Mass Spectrom Rev 2019, 38: 22\u201333.","journal-title":"Mass Spectrom Rev"},{"key":"730_CR66","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijmm.2016.03.006","volume":"306","author":"KS Smirnov","year":"2016","unstructured":"Smirnov KS, Maier TV, Walker A, Heinzmann SS, Forcisi S, Martinez I, et al. Challenges of metabolomics in human gut microbiota research. Int J Med Microbiol 2016, 306: 266\u2013279.","journal-title":"Int J Med Microbiol"},{"key":"730_CR67","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-16-0409","volume":"25","author":"E Loftfield","year":"2016","unstructured":"Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, et al. Comparison of collection methods for fecal samples for discovery metabolomics in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2016, 25: 1483\u20131490.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"730_CR68","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1586\/erm.12.33","volume":"12","author":"T Hy\u00f6tyl\u00e4inen","year":"2012","unstructured":"Hy\u00f6tyl\u00e4inen T. Novel methodologies in metabolic profiling with a focus on molecular diagnostic applications. Expert Rev Mol Diagn 2012, 12: 527\u2013538.","journal-title":"Expert Rev Mol Diagn"},{"key":"730_CR69","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ecco-jcc\/jjw024","volume":"10","author":"M Valles-Colomer","year":"2016","unstructured":"Valles-Colomer M, Darzi Y, Vieira-Silva S, Falony G, Raes J, Joossens M. Meta-omics in inflammatory bowel disease research: Applications, challenges, and guidelines. J Crohns Colitis 2016, 10: 735\u2013746.","journal-title":"J Crohns Colitis"},{"key":"730_CR70","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40168-019-0767-6","volume":"7","author":"X Zhang","year":"2019","unstructured":"Zhang X, Li LY, Butcher J, Stintzi A, Figeys D. Advancing functional and translational microbiome research using meta-omics approaches. Microbiome 2019, 7: 154.","journal-title":"Microbiome"},{"key":"730_CR71","doi-asserted-by":"publisher","first-page":"E4673","DOI":"10.3390\/ijms20194673","volume":"20","author":"CAM Wegh","year":"2019","unstructured":"Wegh CAM, Geerlings SY, Knol J, Roeselers G, Belzer C. Postbiotics and their potential applications in early life nutrition and beyond. Int J Mol Sci 2019, 20: E4673.","journal-title":"Int J Mol Sci"},{"key":"730_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.phrs.2018.03.012","volume":"131","author":"F Pistollato","year":"2018","unstructured":"Pistollato F, Iglesias RC, Ruiz R, Aparicio S, Crespo J, Lopez LD, et al. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer\u2019s disease: A focus on human studies. Pharmacol Res 2018, 131: 32\u201343.","journal-title":"Pharmacol Res"},{"key":"730_CR73","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/nutrit\/nuw023","volume":"74","author":"F Pistollato","year":"2016","unstructured":"Pistollato F, Sumalla Cano S, Elio I, Masias Vergara M, Giampieri F, Battino M. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev 2016, 74: 624\u2013634.","journal-title":"Nutr Rev"},{"key":"730_CR74","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-019-1494-4","volume":"16","author":"F Angelucci","year":"2019","unstructured":"Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and Alzheimer\u2019s disease. J Neuroinflammation 2019, 16: 108.","journal-title":"J Neuroinflammation"},{"key":"730_CR75","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: A randomized, double-blind and controlled trial. Front Aging Neurosci 2016, 8: 256.","journal-title":"Front Aging Neurosci"},{"key":"730_CR76","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.clnu.2018.11.034","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E, et al. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer\u2019s disease: A randomized, double-blind, controlled trial. Clin Nutr 2019, 38: 2569\u20132575.","journal-title":"Clin Nutr"},{"key":"730_CR77","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3920\/BM2014.0177","volume":"6","author":"T Wang","year":"2015","unstructured":"Wang T, Hu X, Liang S, Li W, Wu X, Wang L, et al. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benef Microbes 2015, 6: 707\u2013717.","journal-title":"Benef Microbes"},{"key":"730_CR78","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/pcn.12637","volume":"72","author":"B Yulug","year":"2018","unstructured":"Yulug B, Hanoglu L, Ozansoy M, Is\u0131k D, Kilic U, Kilic E, et al. Therapeutic role of rifampicin in Alzheimer\u2019s disease. Psychiatry Clin Neurosci 2018, 72: 152\u2013159.","journal-title":"Psychiatry Clin Neurosci"},{"key":"730_CR79","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41398-019-0525-3","volume":"9","author":"J Sun","year":"2019","unstructured":"Sun J, Xu J, Ling Y, Wang F, Gong T, Yang C, et al. Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice. Transl Psychiatry 2019, 9: 189. https:\/\/doi.org\/10.1038\/s41398-019-0525-3.","journal-title":"Transl Psychiatry"},{"key":"730_CR80","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1389200219666180813144834","volume":"15","author":"F Leblhuber","year":"2018","unstructured":"Leblhuber F, Steiner K, Schuetz B, Fuchs D, Gostner JM. Probiotic supplementation in patients with Alzheimer\u2019s dementia - an explorative intervention study. Curr Alzheimer Res 2018, 15: 1106\u20131113.","journal-title":"Curr Alzheimer Res"},{"key":"730_CR81","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.1007\/s12035-018-0973-4","volume":"55","author":"L Bonfili","year":"2018","unstructured":"Bonfili L, Cecarini V, Cuccioloni M, Angeletti M, Berardi S, Scarpona S, et al. SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Mol Neurobiol 2018, 55: 7987\u20138000.","journal-title":"Mol Neurobiol"},{"key":"730_CR82","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.3390\/ijms20174121","volume":"20","author":"Parisa Gazerani","year":"2019","unstructured":"Gazerani P. Probiotics for Parkinson\u2019s disease. Int J Mol Sci 2019, 20: 4121.","journal-title":"Int J Mol Sci"},{"key":"730_CR83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10072-018-3641-6","volume":"40","author":"X Fang","year":"2019","unstructured":"Fang X. Microbial treatment: The potential application for Parkinson\u2019s disease. Neurol Sci 2019, 40: 51\u201358.","journal-title":"Neurol Sci"},{"key":"730_CR84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5056\/jnm19044","volume":"25","author":"SK Dutta","year":"2019","unstructured":"Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, et al. Parkinson\u2019s disease: The emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation. J Neurogastroenterol Motil 2019, 25: 363\u2013376.","journal-title":"J Neurogastroenterol Motil"},{"key":"730_CR85","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/CIA.S106284","volume":"11","author":"D Georgescu","year":"2016","unstructured":"Georgescu D, Ancusa OE, Georgescu LA, Ionita I, Reisz D. Nonmotor gastrointestinal disorders in older patients with Parkinson\u2019s disease: Is there hope? Clin Interv Aging 2016, 11: 1601\u20131608.","journal-title":"Clin Interv Aging"},{"key":"730_CR86","first-page":"289","volume":"21","author":"S Borzabadi","year":"2018","unstructured":"Borzabadi S, Oryan S, Eidi A, Aghadavod E, Daneshvar Kakhaki R, Tamtaji OR, et al. The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson\u2019s disease: A randomized, double-blind. PlaceboControlled trial. Arch Iran Med 2018, 21: 289\u2013295.","journal-title":"PlaceboControlled trial. Arch Iran Med"},{"key":"730_CR87","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F, Borzabadi S, et al. Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr 2019, 38: 1031\u20131035.","journal-title":"Clin Nutr"},{"key":"730_CR88","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3389\/fneur.2019.00663","volume":"10","author":"TM Cantu-Jungles","year":"2019","unstructured":"Cantu-Jungles TM, Rasmussen HE, Hamaker BR. Potential of prebiotic butyrogenic fibers in Parkinson\u2019s disease. Front Neurol 2019, 10: 663.","journal-title":"Front Neurol"},{"key":"730_CR89","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","volume":"87","author":"M Barichella","year":"2016","unstructured":"Barichella M, Pacchetti C, Bolliri C, Cassani E, Iorio L, Pusani C, et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT. Neurology 2016, 87: 1274\u20131280.","journal-title":"Neurology"},{"key":"730_CR90","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol 2019, 16: 461\u2013478.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"730_CR91","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12264-019-00410-8","volume":"36","author":"J Bruning","year":"2020","unstructured":"Bruning J, Chapp A, Kaurala GA, Wang RJ, Techtmann S, Chen QH. Gut microbiota and short chain fatty acids: Influence on the autonomic nervous system. Neurosci Bull 2020, 36: 91\u201395.","journal-title":"Neurosci Bull"},{"key":"730_CR92","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/14737175.2018.1400909","volume":"18","author":"L Ho","year":"2018","unstructured":"Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer\u2019s disease-type beta-amyloid neuropathological mechanisms. Expert Rev Neurother 2018, 18: 83\u201390.","journal-title":"Expert Rev Neurother"},{"key":"730_CR93","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li W, Wu XL, Hu X, Wang T, Liang S, Duan YF, et al. Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci China Life Sci 2017, 60: 1223\u20131233.","journal-title":"Sci China Life Sci"},{"key":"730_CR94","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 2016, 32: 66\u201372.","journal-title":"Parkinsonism Relat Disord"},{"key":"730_CR95","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.28016","volume":"35","author":"C Shin","year":"2020","unstructured":"Shin C, Lim Y, Lim H, Ahn TB. Plasma short-chain fatty acids in patients with Parkinson\u2019s disease. Mov Disord 2020, 35: 1021\u20131027.","journal-title":"Mov Disord"},{"key":"730_CR96","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva I, Pinho R, Pavlou MA, Hennion M, Wales P, Sch\u00fctz AL, et al. Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum Mol Genet 2017, 26: 2231\u20132246.","journal-title":"Hum Mol Genet"},{"key":"730_CR97","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD, Yang Q, et al. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: Gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 2018, 70: 48\u201360.","journal-title":"Brain Behav Immun"},{"key":"730_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.aambs.2015.02.001","volume":"91","author":"A Burokas","year":"2015","unstructured":"Burokas A, Moloney RD, Dinan TG, Cryan JF. Microbiota regulation of the Mammalian gut-brain axis. Adv Appl Microbiol 2015, 91: 1\u201362.","journal-title":"Adv Appl Microbiol"},{"key":"730_CR99","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne) 2020, 11: 25.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"730_CR100","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12974-020-02053-3","volume":"18","author":"HM Chi","year":"2021","unstructured":"Chi HM, Cao W, Zhang M, Su DH, Yang HL, Li Z, et al. Environmental noise stress disturbs commensal microbiota homeostasis and induces oxi-inflammmation and AD-like neuropathology through epithelial barrier disruption in the EOAD mouse model. J Neuroinflammation 2021, 18: 9.","journal-title":"J Neuroinflammation"},{"key":"730_CR101","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","volume":"91","author":"J Sun","year":"2021","unstructured":"Sun J, Li HJ, Jin YJ, Yu JH, Mao SY, Su KP, et al. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway. Brain Behav Immun 2021, 91: 703\u2013715.","journal-title":"Brain Behav Immun"},{"key":"730_CR102","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, et al. Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 2017, 32: 739\u2013749.","journal-title":"Mov Disord"},{"key":"730_CR103","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2017.09.023","volume":"61","author":"D Brenner","year":"2018","unstructured":"Brenner D, Hiergeist A, Adis C, Mayer B, Gessner A, Ludolph AC, et al. The fecal microbiome of ALS patients. Neurobiol Aging 2018, 61: 132\u2013137.","journal-title":"Neurobiol Aging"},{"key":"730_CR104","doi-asserted-by":"crossref","unstructured":"Kong G, Cao KL, Judd LM, Li SS, Renoir T, Hannan AJ. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease. Neurobiol Dis 2020, 135: 104268.","DOI":"10.1016\/j.nbd.2018.09.001"},{"key":"730_CR105","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/ajcn\/nqz220","volume":"110","author":"A McCann","year":"2019","unstructured":"McCann A, Jeffery IB, Ouliass B, Ferland G, Fu X, Booth SL, et al. Exploratory analysis of covariation of microbiota-derived vitamin K and cognition in older adults. Am J Clin Nutr 2019, 110: 1404\u20131415.","journal-title":"Am J Clin Nutr"},{"key":"730_CR106","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"YW Qian","year":"2020","unstructured":"Qian YW, Yang XD, Xu SQ, Huang P, Li BY, Du JJ, et al. Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain 2020, 143: 2474\u20132489.","journal-title":"Brain"},{"key":"730_CR107","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","volume":"22","author":"K Nicholson","year":"2021","unstructured":"Nicholson K, Bjornevik K, Abu-Ali G, Chan J, Cortese M, Dedi B, et al. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2021, 22: 186\u2013194.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"730_CR108","doi-asserted-by":"publisher","first-page":"e00325","DOI":"10.1128\/mSystems.00325-19","volume":"4","author":"L Wu","year":"2019","unstructured":"Wu L, Zeng TS, Zinellu A, Rubino S, Kelvin DJ, Carru C (2019) A cross-sectional study of compositional and functional profiles of gut microbiota in Sardinian centenarians. mSystems 2019, 4: e00325\u2013e00319.","journal-title":"mSystems"},{"key":"730_CR109","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.18632\/aging.101693","volume":"10","author":"WJ Peng","year":"2018","unstructured":"Peng WJ, Yi PJ, Yang JJ, Xu PP, Wang Y, Zhang ZY, et al. Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer\u2019s Disease using 16S rRNA gene and metagenomic sequencing analysis. Aging (Albany NY) 2018, 10: 4054\u20134065.","journal-title":"Aging (Albany NY)"},{"key":"730_CR110","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart A, Pandey U, Wicke T, Sixel-D\u00f6ring F, Janzen A, Sittig-Wiegand E, et al. The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord 2018, 33: 88\u201398.","journal-title":"Mov Disord"},{"key":"730_CR111","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF, et al. Gut microbial ecosystem in parkinson disease: New clinicobiological insights from multi-omics. Ann Neurol 2021, 89: 546\u2013559.","journal-title":"Ann Neurol"},{"key":"730_CR112","doi-asserted-by":"publisher","first-page":"104312","DOI":"10.1016\/j.phrs.2019.104312","volume":"146","author":"YY Hor","year":"2019","unstructured":"Hor YY, Lew LC, Jaafar MH, Lau AS, Ong JS, Kato T, et al. Lactobacillus sp improved microbiota and metabolite profiles of aging rats. Pharmacol Res 2019, 146: 104312.","journal-title":"Pharmacol Res"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-021-00730-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-021-00730-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-021-00730-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T12:31:46Z","timestamp":1675513906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-021-00730-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":112,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1007\/s12264-021-00730-8","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"22 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}